Cochrane Taiwan announces appointment of new Director

Cochrane Taiwan announces appointment of new Director

We are pleased to announce that Cochrane Taiwan has appointed Chiehfeng (Cliff) Chen as its new Director, effective February 2017.

Cochrane Taiwan’s work in supporting and promoting evidence-based health care goes back to 2003, and Cliff has been involved with the team’s activities for 11 years. Under the leadership of Founding Director Ken Kuo, the Cochrane Taiwan team has been instrumental in establishing the Center for Evidence-Based Medicine at Taipei Medical University with government support for initiatives including funding for Cochrane Library access for all Ministry of Health and Welfare affiliated hospitals.

Cochrane Taiwan’s many other accomplishments include their key role in establishing an informal alliance of countries in East Asia in 2007 that meets annually and provides opportunities for training in systematic reviews. Taiwanese people are frequent users of the Library, often in the top ten of countries for full-text downloads, at the top of the list of non-English speaking countries for many years. Taiwan has made around 3,800 Cochrane Review abstracts available in Traditional Chinese; these have been translated by an active network of 500 clinicians. 

Ken will be stepping down from managing day-to-day operations but will continue to provide advisory support and contributions to the team’s work.

Cochrane CEO Mark Wilson said, ‘I congratulate and warmly welcome Cliff to his new role. This opens a new chapter for the Cochrane Taiwan team following the outstanding leadership of Ken Kuo in supporting and promoting evidence-based health care over more than a decade. I look forward immensely to working with Cliff in his new role and the great team at Cochrane Taiwan.’

Please join us in congratulating Ken, Cliff, and Cochrane Taiwan as they begin this new era, and wishing them every success for the future.

Find out more about Cochrane Taiwan's work

Friday, April 28, 2017
Share/Save